17:28 EDT Viking Therapeutics up 7% at $11.52 after Phase 1 clinical trial data for VK2735
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VKTX:
- Viking Therapeutics announces results from Phase 1 clinical trial of VK2735
- Viking announces presentation on clinical trial of VK2735 at ObesityWeek 2023
- Viking Therapeutics call volume above normal and directionally bullish
- Viking Therapeutics recent 50% selloff ‘excessive,’ says William Blair
- Biotech Alert: Searches spiking for these stocks today